Cargando…
Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients
The traditional Japanese (Kampo) medicine, kakkonto with shosaikotokakikyosekko, has antiviral and anti-inflammatory effects. In this randomized trial, patients with mild and moderate coronavirus disease (COVID-19) were randomly allocated to the control group receiving conventional treatment for sym...
Autores principales: | Takayama, Shin, Namiki, Takao, Arita, Ryutaro, Ono, Rie, Kikuchi, Akiko, Ohsawa, Minoru, Saito, Natsumi, Suzuki, Satoko, Nakae, Hajime, Kobayashi, Seiichi, Yoshino, Tetsuhiro, Ishigami, Tomoaki, Tanaka, Koichiro, Nochioka, Kotaro, Takagi, Airi, Mimura, Masaru, Yamaguchi, Takuhiro, Ishii, Tadashi, Hisanaga, Akito, Mitani, Kazuo, Ito, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682103/ https://www.ncbi.nlm.nih.gov/pubmed/36438822 http://dx.doi.org/10.3389/fphar.2022.1008946 |
Ejemplares similares
-
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
por: Takayama, Shin, et al.
Publicado: (2020) -
Kakkonto, shosaikoto,
Platycodon grandiflorum
root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID‐19
por: Arita, Ryutaro, et al.
Publicado: (2020) -
Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)
por: Takayama, Shin, et al.
Publicado: (2022) -
Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials
por: Takayama, Shin, et al.
Publicado: (2021) -
A case of tetanus treated with Kampo medicines such as Kakkonto and Shakuyakukanzoto
por: Nakae, Hajime, et al.
Publicado: (2016)